Structure-activity relationships of histamine H2 receptor ligands

被引：31

作者：

Dove, S

Elz, S

Seifert, R

Buschauer, A ^{[1
]}

机构：

[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany

[2] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 09期

关键词：

H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis;

D O I：

10.2174/1389557043403242

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Recent research on histamine H-2 receptor agonists was focused on quantitative structure-activity relationships and receptor models explaining the activity of imidazolylpropylguanidines. Their selectivity for guinea pig vs. human isoforms was investigated using H-2 receptor-G(salpha) fusion proteins and attributed to amino acid differences in transmembrane domains 1 and 7. New antagonists result from approaches to improve pharmacokinetic properties and to design hybrid drugs which additionally have gastroprotective or anti H. pylori activity.

引用

页码：941 / 954

页数：14

共 50 条

[41] Novel Ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
Stankova, Magda
Cai, Minying
Cabello, Chris
DeCot, Bridgette
Krchnak, Victor, Jr.
Hruby, Victor J.
PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 649 - 650
[42] Synthesis and structure-activity relationships of new adenine derivatives as ligands for the rat adenine receptor
Borrmann, Thomas
Abdelrahman, Aliaa
Gorzalka, Simone
Schiedel, Anke
Mueller, Christa E.
PURINERGIC SIGNALLING, 2008, 4 : S13 - S13
[43] Novel ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
Stankova, M
Cai, M
Cabello, C
DeCot, B
Krchnak, V
Hruby, VJ
BIOPOLYMERS, 2003, 71 (03) : 309 - 309
[44] Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligands
Farmer, LJ
Zhi, L
Jeong, S
Kallel, EA
Croston, G
Flatten, KS
Heyman, RA
Nadzan, AM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) : 2747 - 2752
[45] Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands
Kim, KH
Lin, NH
Anderson, DJ
BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (12) : 2211 - 2217
[46] MEDI 11-Synthesis and structure-activity relationships of a series of sigma receptor ligands
Somu, Ravindranadh V.
Wilson, Daniel
Qiao, Chunhua
Vannada, Jagadeswar
Bennett, Eric
Boshoff, Helena
Barry, Clifton E., III
Aldrich, Courtney C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 850 - 850
[47] Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) : 1815 - 1826
[48] Structure-activity relationships of N-substituted ligands for the α7 nicotinic acetylcholine receptor
Mortell, Kathleen H.
Schrimpf, Michael R.
Bunnelle, William H.
Anderson, David J.
Gronlien, Jens Halvard
Hagene, Kirsten Thorin
Gopalakrishnan, Murali
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 104 - 107
[49] Synthesis and structure-activity relationships of new non-steroidal progesterone receptor ligands
Kurihara, K
Tanabe, K
Yamamoto, Y
Shinei, R
Ajito, K
Okonogi, T
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1837 - 1842
[50] Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands
Corrado, Sandra
Battisti, Umberto M.
Sorbi, Claudia
Tait, Annalisa
Malfacini, Davide
Camarda, Valeria
Calo, Girolamo
Brasili, Livio
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 447 - 458

← 1 2 3 4 5 →